Despite Guidelines, Some with Metastatic Colon Cancer Not Tested for Biomarkers
Despite guideline recommendations for biomarker testing and significant therapeutic recommendations, a study published in JCO Precision Oncology indicated that 40% of all patients with metastatic colon cancer are not tested, according to guidelines.
Adherence to the guideline recommendations would potentially reduce exposure to expensive and less effective therapies, resulting in improved patient outcomes.
Return to “Colon Talk - Colon cancer (colorectal cancer) support forum”
Users browsing this forum: Google [Bot] and 154 guests